tirzepatide nausea Why Does Cause and What Can I Do About It? Does Tirzepatide Make You Feel

Groeneveld, S

This effect was primarily mediated through weight loss, with different degrees of contributions from weight-loss independent effects across the different SURPASS trials

Contact your healthcare provider if side effects become severe or interfere with daily activities

Description Tirzepatide: Complete Research Guide Dual GIP/GLP-1 Receptor Agonist Mechanisms, Clinical Evidence, and Metabolic Research Last updated: March 2026 Executive Summary Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly and Company